Life Technologies Corporation operates as a global life sciences company. The company’s Molecular Biology Systems division offers molecular biology-based technologies, including basic and real-time PCR, RNA interference, DNA synthesis, sample preparation, transfection, cloning and protein expression profiling, protein analysis, and thermo-cycler instrumentation technologies. Its Cell Systems division provides cell culture media and sera, stem cells and related tools, cellular imaging products, antibodies, drug discovery services, and cell therapy related products used in the study of cell function. The company’s Genetic Systems division offers capillary electrophoresis systems and reagents, and next generation sequencing systems and reagents comprising SOLiD and Ion Torrent systems, as well as reagent kits developed specifically for applied markets, such as forensics and food safety, pharmaceutical quality monitoring, and animal health markets. Life Technologies Corporation also provides repair and maintenance services; and custom services, such as cell line development, custom media modification, and primers and custom assays development services. Its products offer research tools for genomics studies, proteomics studies, gene splicing, cellular analysis, and other research applications required by laboratories associated with universities, medical research centers, and government and other research institutions, as well as biotechnology, pharmaceutical, and chemical companies; and serves clinical labs, medical institutions, medical researchers, and various industries through sales and service professionals, e-commerce capabilities, and onsite supply center solutions. Life Technologies Corporation has collaborations with the Structural Genomics Consortium; and Southern African Treatment and Resistance Network. The company was founded in 1987 and is headquartered in Carlsbad, California.